Please use this identifier to cite or link to this item:
Title: Structural and functional characterization of TRX16, a thioredoxinlike protein and altering substrate specificity of a serine protease inhibitor
Keywords: Thioredoxin-related protein, NF-κB, free radicals, antioxidant, NMR-Spectroscopy ,X-ray,Thrombin inhibitor
Issue Date: 10-Nov-2011
Citation: PANKAJ KUMAR GIRI (2011-11-10). Structural and functional characterization of TRX16, a thioredoxinlike protein and altering substrate specificity of a serine protease inhibitor. ScholarBank@NUS Repository.
Abstract: The causative agents of most diseases like cancer and Alzheimer¿s are proteins. The function of a protein can be fully appreciated only when the complete knowledge of its 3-dimensional structure is known. First part of my thesis deals with the proteins that are involved in gene regulation under stress by interacting with its partners and the second project uses a rational approach for protein design and engineering to change the substrate specificity of a protease inhibitor. Carcinoscorpius rotundicauda thioredoxin (Trx) like protein (Cr-TRP16) is a Trx like protein that contains a conserved WCPPC motif. We have determined the NMR structure of the reduced form of Cr-TRP16, and elucidated the molecular mechanism by which NF-¿B activation is regulated through Cr-TRP16 (Giri et al., J Biol Chem. M112.379859, 2012). Besides, we have expressed and purified the human thioredoxin like protein-6 (TXNL-6), a homolog of Cr-TRP16, which protects retinal cells from apoptosis under stress and characterized its interaction with NF-kB. These studies help further in understanding the interaction of Trx and Trx-like proteins with other metabolic pathways and will lead to promising therapeutic development. The second project reports the structural basis for the rational design of altered specificity of a protease inhibitor. Protease inhibitors play a decisive role in maintaining homeostasis and eliciting antimicrobial activities. CrSPI-1 is a protease inhibitor identified from Carcinoscorpius rotundicauda. Here, we illustrate the use its structure to modify CrSPI-1-D1 to a potent thrombin inhibitor with IC50 of 26.3 nM (Giri et al., PloS ONE 5, e15258, 2010). This study will lead to the modification of a multi-domain inhibitor to target several proteases.
Appears in Collections:Ph.D Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
GIRI PK.pdf5.22 MBAdobe PDF



Page view(s)

checked on Dec 16, 2018


checked on Dec 16, 2018

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.